Skip to main content

Dr. Jorge Castillo, MD

Hematology (Hematology (Internal Medicine) Physician)

  • Medicare participating

At a glance

Years since graduation
30
In the NPI registry since
2007
Medicare patients seen, 2024
457

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology (Internal Medicine) Physician primary
    MA license 257257 · RI license LP00533

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
457
Services billed
936
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes271205
Established patient office or other outpatient visit, 40-54 minutes220182
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes8731
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes5422
New patient office or other outpatient visit, 60-74 minutes5050
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or4242
Telephone medical discussion with physician, 21-30 minutes2017
Hospital discharge day management, 30 minutes or less1818

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Brukinsa (zanubrutinib)167
Imbruvica (ibrutinib)134
Venclexta (venetoclax)23

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 7 companies reported 18 payments worth $14,561 in total to this clinician.

By company
Beone Medicines USA, Inc.$7,865
AbbVie Inc.$4,950
Beone Medicines LTD.$1,060
Lantheus Medical Imaging, Inc.$490
Recordati_rare_diseases_inc.$83.73
Genmab U.S., Inc.$59.99
AstraZeneca Pharmaceuticals LP$52.73
By type
Consulting Fee$11,300
Travel and Lodging$2,679
Food and Beverage$583

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Apr 4, 2025AbbVie Inc.
Apr 4, 2025
Consulting Fee
IMBRUVICA · ONCOLOGY
$4,950
Oct 14, 2025Beone Medicines USA, Inc.
Oct 14, 2025
Consulting Fee$4,800
Jun 19, 2025Beone Medicines LTD.
Jun 19, 2025
Consulting Fee$610
Nov 7, 2025Beone Medicines USA, Inc.
Nov 7, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Cleveland, OH · in-kind
$493
Jul 14, 2025Lantheus Medical Imaging, Inc.
Jul 14, 2025
Consulting Fee$490
Jun 30, 2025Beone Medicines LTD.
Jun 30, 2025
Consulting Fee$450
Nov 5, 2025Beone Medicines USA, Inc.
Nov 5, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Denver, CO · in-kind
$449
Nov 6, 2025Beone Medicines USA, Inc.
Nov 6, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Cleveland, OH · in-kind
$449
Nov 5, 2025Beone Medicines USA, Inc.
Nov 5, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Denver, CO · in-kind
$449
Nov 5, 2025Beone Medicines USA, Inc.
Nov 5, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Denver, CO · in-kind
$394
All 12 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Nov 7, 2025Beone Medicines USA, Inc.
Nov 7, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Cleveland, OH · in-kind
$493
Nov 6, 2025Beone Medicines USA, Inc.
Nov 6, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Cleveland, OH · in-kind
$449
Nov 6, 2025Beone Medicines USA, Inc.
Nov 6, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Cleveland, OH · in-kind
$246
Nov 6, 2025Beone Medicines USA, Inc.
Nov 6, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Cleveland, OH · in-kind
$200
Nov 5, 2025Beone Medicines USA, Inc.
Nov 5, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Denver, CO · in-kind
$449
Nov 5, 2025Beone Medicines USA, Inc.
Nov 5, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Denver, CO · in-kind
$449
Nov 5, 2025Beone Medicines USA, Inc.
Nov 5, 2025
Travel and Lodging
BRUKINSA · Oncology · travel to Denver, CO · in-kind
$394
Oct 14, 2025Beone Medicines USA, Inc.
Oct 14, 2025
Consulting Fee$4,800
Jul 14, 2025Lantheus Medical Imaging, Inc.
Jul 14, 2025
Consulting Fee$490
Jun 30, 2025Beone Medicines LTD.
Jun 30, 2025
Consulting Fee$450
Jun 19, 2025Beone Medicines LTD.
Jun 19, 2025
Consulting Fee$610
Apr 4, 2025AbbVie Inc.
Apr 4, 2025
Consulting Fee
IMBRUVICA · ONCOLOGY
$4,950

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Massachusetts →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $1,246,678 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology clinicians in Boston

Sources

NPI registry (CMS NPPES, November 2026; record last updated March 6, 2026), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1689891129. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.